Free Trial
→ Trump’s treachery (From Porter & Company) (Ad) Buy NRSNW Stock  Free NRSNW Stock Alerts

NeuroSense Therapeutics (NRSNW) SEC Filings & 10K Form

$0.70 -0.10 (-12.50%)
As of 06/20/2025 01:15 PM Eastern
Compare

Recent NeuroSense Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/07/2025
8:10 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2025
8:25 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
04/16/2025
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
04/11/2025
3:00 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form POS AM
04/11/2025
3:00 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form POS AM
04/07/2025
4:25 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
7:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2025
7:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2025
8:13 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
01/06/2025
9:40 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2024
3:47 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
12/23/2024
8:04 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2024
10:06 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
1:42 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
12/12/2024
4:08 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
12/04/2024
7:32 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
3:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/24/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
11/22/2024
3:30 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
10/31/2024
3:59 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
8:45 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
7:35 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/24/2024
7:30 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
8:35 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2024
8:13 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
10/01/2024
5:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form POS AM
09/30/2024
3:53 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
8:25 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
5:10 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
5:10 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
4:00 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/28/2024
6:05 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
7:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
8:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
8:24 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2024
8:29 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2024
8:11 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Elon’s BIGGEST warning yet? (Ad)

Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.

Click here to see why Tesla's about to prove everyone wrong... again.
07/01/2024
7:05 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:20 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
06/27/2024
7:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:16 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
06/24/2024
8:20 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NRSNW) was last updated on 6/22/2025 by MarketBeat.com Staff
From Our Partners
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
Gold is soaring. Here’s how to get paid from it
Gold just broke through $3,300… And while the headlines shout about price targets, something even more powe...
Investors Alley | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
379 passengers walked away from this
Forget OpenAI, ChatGPT, and the $2 trillion chip race… The real story is buried inside a new U.S. patent. E...
True Market Insiders | Sponsored
A grave, grave error.
It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...
Porter & Company | Sponsored